Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Medtronic Stock Quote

Medtronic (NYSE: MDT)

Price as of June 25, 2024, 2:05 p.m. ET

Medtronic Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
MDT -5.01% -4.89% -1.00% +109,621%
S&P +25.29% +86.97% +13.33% +5,620%

Medtronic Company Info

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.

News & Analysis

The Fool has written over 700 articles on Medtronic.


Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.